| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 3 |
| 1 | CYCLOPHOSPHAMIDE | 2 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 4 | DOXORUBICIN | 2 |
| 5 | CARMUSTINE | 1 |
| 6 | CISPLATIN | 1 |
| 7 | CYTARABINE | 1 |
| 8 | DEXAMETHASONE | 1 |
| 9 | DEXAMETHASONE 1.5 MG | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| 1 | CARMUSTINE | 1 | 0.0002 |
| 2 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 3 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 4 | MELPHALAN HYDROCHLORIDE | 1 | 0.0000 |
| 5 | DOXORUBICIN | 2 | 0.0000 |
| 6 | CYTARABINE | 1 | 0.0000 |
| 7 | FLUCONAZOLE | 1 | 0.0000 |
| 8 | RITUXIMAB | 3 | 0.0000 |
| 9 | ETOPOSIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 3 |
| 1 | Alkylating Drug [EPC] | 2 |
| 2 | Corticosteroid [EPC] | 2 |
| 3 | Azole Antifungal [EPC] | 1 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| 5 | Platinum-based Drug [EPC] | 1 |
| 6 | Topoisomerase Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 3 | 0.0000 |
| 2 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 3 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Corticosteroid [EPC] | 2 | 0.0000 |